Description
Class C07J : STEROIDS
Subclass 63/00: Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
C07J 63/00
Sub-Class
Stats
- 135 US PATENTS IN FORCE
- 63 US APPLICATIONS PENDING
- 53 Total Patent Owners
- 481 TOTAL INVENTORS
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 12264178 | Ursolic acid morpholine and diethanolamine salts | Oct 09, 24 | Apr 01, 25 | EMMYON, INC. |
| 12258370 | Betulastatin compounds | Feb 08, 23 | Mar 25, 25 | Arizona Board of Regents on behalf of Arizona State University |
| 12227540 | Saponin purification | Jan 19, 23 | Feb 18, 25 | GlaxoSmithKline Biologicals SA |
| 12221461 | Saponin adjuvant and evaluation method thereof | Mar 27, 19 | Feb 11, 25 | OBI PHARMA INC. |
| 12065464 | 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof | Jun 25, 21 | Aug 20, 24 | REATA PHARMACEUTICALS HOLDINGS, LLC |
| 12037355 | Triterpene saponin analogues | Mar 08, 23 | Jul 16, 24 | ADJUVANCE TECHNOLOGIES, INC.; Memorial Sloan Kettering Cancer Center; |
| 11939353 | Fluorinated and alkylated bile acids | Jul 16, 21 | Mar 26, 24 | Metselex, Inc. |
| 11919838 | Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17 | Jul 09, 21 | Mar 05, 24 | REATA PHARMACEUTICALS HOLDINGS, LLC |
| 11896672 | Targeted nucleic acid conjugate compositions | Apr 11, 17 | Feb 13, 24 | ARBUTUS BIOPHARMA CORPORATION |
| 11873320 | 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof | Aug 06, 21 | Jan 16, 24 | REATA PHARMACEUTICALS HOLDINGS, LLC |
| 11858959 | Glycyrrhetinic acid derivatives for use in treating hyperkalemia | Feb 06, 20 | Jan 02, 24 | Ardelyx, Inc. |
| 11768319 | Glycyrrhetinic acid derivatives for treating hyperkalemia | Aug 06, 18 | Sep 26, 23 | Ardelyx, Inc. |
| 11753436 | Analogs of celastrol | Apr 15, 20 | Sep 12, 23 | ERX Pharmaceuticals Corporation |
| 11629162 | Triterpene saponin variants, methods of synthesis and use thereof | Dec 19, 16 | Apr 18, 23 | Memorial Sloan-Kettering Cancer Center |
| 11591364 | Saponin purification | Nov 30, 18 | Feb 28, 23 | GlaxoSmithKline Biologicals SA |
| 11584775 | C4-modified oleanolic acid derivatives for inhibition of IL-17 and other uses | Sep 23, 16 | Feb 21, 23 | Reata Pharmaceuticals, Inc. |
| 11485755 | Natural and synthetic compounds for treating cancer and other diseases | Feb 17, 20 | Nov 01, 22 | Not available |
| 11464790 | Triterpenoids with HIV maturation inhibitory activity | Aug 03, 20 | Oct 11, 22 | ViiV Healthcare UK (No.4) Limited |
| 11406648 | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof | Dec 28, 20 | Aug 09, 22 | Reata Pharmaceuticals, Inc. |
| 11236122 | Triterpene amine derivatives | Jun 28, 19 | Feb 01, 22 | DFH THERAPEUTICS, INC.; The United States of America as represented by the Secretary Department of Health and Human Services; |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2025/0099,594 | TARGETED COMPOSITIONS | Sep 12, 24 | Mar 27, 25 | ARBUTUS BIOPHARMA CORPORATION |
| 2025/0092,085 | SAPONIN-BASED ADJUVANTS AND VACCINES | Dec 02, 22 | Mar 20, 25 | Not available |
| 2025/0092,086 | CELASTROL SALTS, CRYSTALLINE FORMS, AND USES THEREOF | Nov 13, 24 | Mar 20, 25 | Not available |
| 2025/0067,907 | COMPOUNDS AND METHODS FOR TREATING HYPERKALEMIA | Sep 03, 24 | Feb 27, 25 | Ardelyx, Inc. |
| 2025/0051,388 | 2,2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF | Jul 09, 24 | Feb 13, 25 | REATA PHARMACEUTICALS HOLDINGS, LLC |
| 2025/0034,202 | CELASTROL PROTEOLYSIS TARGETING CHIMERAS | Nov 10, 22 | Jan 30, 25 | Not available |
| 2024/0368,214 | POSITIVE NMDA-MODULATING COMPOUNDS AND METHODS OF USE THEREOF | Aug 25, 22 | Nov 07, 24 | Not available |
| 2024/0327,443 | TRITERPENE SAPONIN ANALOGUES | Jun 04, 24 | Oct 03, 24 | ADJUVANCE TECHNOLOGIES, INC.; Memorial Sloan Kettering Cancer Center; |
| 2024/0317,676 | ANTIOXIDANT INFLAMMATION MODULATORS: OLEANOLIC ACID DERIVATIVES WITH AMINO AND OTHER MODIFICATIONS AT C-17 | Feb 06, 24 | Sep 26, 24 | REATA PHARMACEUTICALS HOLDINGS, LLC |
| 2024/0300,996 | COMPOUNDS FOR TREATING CNS DISORDERS | Sep 25, 23 | Sep 12, 24 | Not available |
| 2024/0294,567 | FLUORINATED AND ALKYLATED BILE ACIDS | Feb 20, 24 | Sep 05, 24 | Not available |
| 2024/0270,786 | STEROID COMPOUNDS | Dec 20, 23 | Aug 15, 24 | Not available |
| 2024/0262,860 | PENTACYCLIC TRITERPENOID GLYCOSIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Jul 05, 21 | Aug 08, 24 | Not available |
| 2024/0245,784 | TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS | Jan 10, 24 | Jul 25, 24 | ARBUTUS BIOPHARMA CORPORATION |
| 2024/0228,528 | 2,2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF | Jan 12, 24 | Jul 11, 24 | REATA PHARMACEUTICALS HOLDINGS, LLC |
| 2024/0209,019 | COMPOUNDS AND METHODS FOR TREATING HYPERKALEMIA | Nov 22, 23 | Jun 27, 24 | Ardelyx, Inc. |
| 2024/0190,911 | ANALOGS OF CELASTROL | Jul 17, 23 | Jun 13, 24 | Not available |
| 2024/0140,986 | SYNTHETIC URSOLIC ACID DERIVATIVES AND METHODS OF USE THEREOF | Jan 18, 22 | May 02, 24 | Not available |
| 2024/0101,592 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | Nov 22, 21 | Mar 28, 24 | Not available |
| 2024/0101,593 | URSOLIC ACID PREPARATIONS AND USES THEREOF | Feb 04, 22 | Mar 28, 24 | Not available |
Top Owners in This Subclass
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 26 Months (last 2 years Issuances)
- 26 Months (last 5 years Issuances)